Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$8.13 - $10.2 $488,613 - $613,020
-60,100 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$5.69 - $8.17 $97,299 - $139,707
17,100 Added 39.77%
60,100 $399,000
Q4 2019

Jan 27, 2020

BUY
$7.07 - $11.61 $197,253 - $323,919
27,900 Added 184.77%
43,000 $386,000
Q2 2019

Aug 15, 2019

BUY
$9.2 - $15.7 $138,920 - $237,070
15,100 New
15,100 $168,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.